Do you want to read an article? Please log in or register.
Longitudinal association between muscle loss and mortality in ever-smokers
COPD
RECOMMENDED
Related content
RECOMMENDED
COPD
Respiratory exacerbations are associated with muscle loss in current and former smokers
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Thorax
Mason SE, Moreta-Martinez R, Labaki WW, Strand M, Baraghoshi D, Regan EA, Bon J, San Jose Estepar R, Casaburi R, McDonald MN, Rossiter H, Make BJ, Dransfield MT, Han MK, Young KA, Kinney G, Hokanson JE, San Jose Estepar R, Washko GR, COPDGene Investigators., COPDGene® Investigators.
doi: 10.1136/thoraxjnl-2020-215999
Emphysema
Pectoralis muscle area and mortality in smokers without airflow obstruction
Respir Res.
Diaz AA, Martinez CH, Harmouche R, Young TP, McDonald ML, Ross JC, Han ML, Bowler R, Make B, Regan EA, Silverman EK, Crapo J, Boriek AM, Kinney GL, Hokanson JE, Estepar RSJ, Washko GR
doi: 10.1186/s12931-018-0771-6.
ARDS
Associations of the plasma lipidome with mortality in the acute respiratory distress syndrome: a longitudinal cohort study
Respir Res.
Maile MD, Standiford TJ, Engoren MC, Stringer KA, Jewell ES, Rajendiran TM, Soni T, Burant CF
doi: 10.1186/s12931-018-0758-3.
RECOMMENDED
COPD
DNA Methylation is Predictive of Mortality in Current and Former Smokers
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Am J Respir Crit Care Med.
Morrow JD, Make B, Regan E, Han M, Hersh CP, Tal-Singer R, Quackenbush J, Choi AMK, Silverman EK, DeMeo DL
doi: 10.1164/rccm.201902-0439OC.
RECOMMENDED
Further Publications
Pulmonary Artery Enlargement is Associated with Exacerbations and Mortality in Ever-Smokers with Preserved Ratio Impaired Spirometry (PRISm)
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Am J Respir Crit Care Med
Wade RC, Simmons JP, Boueiz A, Gregory A, Wan ES, Regan EA, Bhatt SP, Han MK, Bowler RP, Crapo JD, Silverman EK, Washko GR, Dransfield MT, Wells JM
doi: 10.1164/rccm.202103-0619LE
COPD
Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort
Ann Am Thorac Soc.
Martinez CH, Murray S, Barr RG, Bleecker E, Bowler RP, Christenson SA, Comellas AP, Cooper CB, Couper D, Criner GJ, Curtis JL, Dransfield MT, Hansel NN, Hoffman EA, Kanner RE, Kleerup E, Krishnan JA, Lazarus SC, Leidy NK, O'Neal W, Martinez FJ, Paine R 3rd, Rennard SI, Tashkin DP, Woodruff PG, Han MK; Subpopulations and Intermediate Outcome Measures in COPD Study Investigators
doi: 10.1513/
RECOMMENDED
Emphysema
DSP variants may be associated with longitudinal change in quantitative emphysema
Respir Res.
Kim W, Cho MH, Sakornsakolpat P, Lynch DA, Coxson HO, Tal-Singer R, Silverman EK, Beaty TH
doi: 10.1186/s12931-
RECOMMENDED
EmphysemaInterstitial Lung DiseasePneumonia
Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Res
Qiu M, Jiang J, Nian X, Wang Y, Yu P, Song J, Zou S
doi: 10.1186/s12931-021-01856-z
PHARMA NEWS
Interstitial Lung Disease
Phase III study showed nintedanib slows the loss of pulmonary function in people living with systemic sclerosis associated ILD1
doi: 10.1056/NEJMoa1903076